Trials / Conditions / Lichen Planopilaris

Lichen Planopilaris

11 registered clinical trials studyying Lichen Planopilaris — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Al NCT07487948	Icahn School of Medicine at Mount Sinai	Phase 2
Recruiting	A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris NCT07532603	Priovant Therapeutics, Inc.	Phase 2 / Phase 3
Recruiting	The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine NCT06512753	Erasmus Medical Center	—
Completed	A Study of Deucravacitinib to Treat LPP and FFA NCT06091956	Mayo Clinic	Phase 2
Completed	a Retrospective Study on the Systemic Treatment of LPP and FFA NCT06512766	Erasmus Medical Center	—
Completed	Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris NCT05030415	University of New Mexico	EARLY_Phase 1
Completed	Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia NCT04409041	Washington University School of Medicine	Phase 2
Completed	Valchlor in the Treatment of Lichen Planopilaris NCT03417141	Mayo Clinic	Phase 2
Unknown	Design and Validation of a New Assessment Tool for Lichen Planopilaris NCT03082560	Massachusetts General Hospital	—
Completed	Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia NCT03346668	University of Minnesota	EARLY_Phase 1
Completed	Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia NCT00691769	Wake Forest University	—